Technology News and Research

RSS

New project aims to track coronavirus using human waste

Recent studies in the Netherlands and other places have shown that the presence of SARS-Coronavirus-2, or the novel coronavirus, can be detected in human waste.

24 Jun 2020

Researchers develop a noninvasive technology to destroy cancer cells

An international research team led by Dr. Tali Ilovitsh of the Biomedical Engineering Department at Tel Aviv University developed a noninvasive technology platform for gene delivery into breast cancer cells.

24 Jun 2020

'Very low' risk of adverse health effects related to RF exposure from 5G systems

Experts weigh in on recent online reports that warn of frightening health consequences from new fifth generation (5G) wireless networks.

24 Jun 2020

New virtual incubator can catalyze early-stage drug discovery and development

Samsara BioCapital, a leading life sciences investment firm, Evotec SE, a global drug discovery alliance and development partnership company (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809), and KCK Ltd., a family investment fund, today announced the launch of Autobahn Labs, a novel virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development.

24 Jun 2020

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Avacta Group plc is pleased to announce that the rapid test strips to detect SARS-COV-2 spike protein have been evaluated by Avacta’s partners at Cytiva.

From Cytiva Life Sciences 24 Jun 2020

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused over 9.263 million cases and taken more than 477,000 lives as of June 24, 2020 – just six months after the initial outbreak in Wuhan, China, was reported. The illness, called COVID-19 disease, caused by SARS-CoV-2 is a severe pneumonic illness, caused by the entry of the virus into the type II alveolar cells.

24 Jun 2020

COVID-READY supports hotels around the world during and after the pandemic

With hotels reopening after the corona lockdown, there is a lot to consider for them to protect their guests and employees as well as possible.

23 Jun 2020

Study explores the heritability of affectionate communication

A new study of twins finds that genetics play a significant role in how affectionate women are, but the same can't be said for men.

23 Jun 2020

Standard smartphone technology can be adapted to image skin lesions

An article published in the Journal of Biomedical Optics (JBO), "Point-of-care, multispectral, smartphone-based dermascopes for dermal lesion screening and erythema monitoring," shows that standard smartphone technology can be adapted to image skin lesions, providing a low-cost, accessible medical diagnostic tool for skin cancer.

23 Jun 2020

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies

23 Jun 2020

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting, and in select cases, undesired weight loss.

23 Jun 2020

Three-quarters of U.S. workers can't work from home, face increased risk of exposure to COVID-19

About three-quarters of U.S. workers, or 108 million people, are in jobs that cannot be done from home during a pandemic, putting these workers at increased risk of exposure to disease.

23 Jun 2020

Research highlights critical barriers that can limit patients' access to medications

Nearly 70 percent of patients have made personal or financial sacrifices to afford prescribed medications according to new research released by CoverMyMeds, highlighting the impact of one of the most common medication access challenges.

23 Jun 2020

Blocking a pair of sugar-transporting proteins impairs lung tumor growth

Blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer, suggests a new study in mice and human cells published today in eLife.

23 Jun 2020

Research brings 3D-printed circuit education tool for people with visual impairments

A research project that aims to help people that are blind or that have other visual impairments learn computer circuit design was recognized recently by a global conference on human-computer interaction.

23 Jun 2020

Hungarian physician to receive the Körber Prize for European Science 2020

The Körber Prize for European Science 2020, which is endowed with one million euros, is being awarded to the Hungarian physician Botond Roska.

23 Jun 2020

GlobalData: NGS technology most likely to provide relief for global backlog of COVID-19 testing

Illumina receiving emergency use authorization from the Food and Drug Administration for diagnosing COVID-19 using its next generation sequencing technology could not have come at a more critical period during this pandemic.

23 Jun 2020

Nicoya receives NRC IRAP funding to develop saliva-based diagnostic test for COVID-19

Nicoya, a leading provider of advanced analytical instruments for the biotechnology and pharmaceutical industries, will receive advisory services and up to $299,190 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program to develop a portable COVID-19 diagnostic test called Atlas.

From Nicoya Lifesciences 23 Jun 2020

Lehigh University receives funding to create functional material that kills coronavirus

Lehigh is one of four universities to receive funding through the Manufacturing PA Innovation Program COVID-19 Challenge supporting innovative research projects that could potentially impact Pennsylvania's pandemic response.

23 Jun 2020

Scientists create 'all-atom' model of SARS-CoV-2 spike protein

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus disease (COVID-19), an illness that has spread across the globe, infecting more than 9 million people. The novel coronavirus invades cells through "spike proteins," which sticks and binds itself to a host cell.

23 Jun 2020

Technology News and Research

New project aims to track coronavirus using human waste

Researchers develop a noninvasive technology to destroy cancer cells

'Very low' risk of adverse health effects related to RF exposure from 5G systems

New virtual incubator can catalyze early-stage drug discovery and development

Avacta provides update on COVID-19 rapid antigen test development partnership with Cytiva

Abnormal findings in testicular tissue of COVID-19 patients, SARS-CoV-2 mostly undetected

COVID-READY supports hotels around the world during and after the pandemic

Study explores the heritability of affectionate communication

Standard smartphone technology can be adapted to image skin lesions

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Three-quarters of U.S. workers can't work from home, face increased risk of exposure to COVID-19

Research highlights critical barriers that can limit patients' access to medications

Blocking a pair of sugar-transporting proteins impairs lung tumor growth

Research brings 3D-printed circuit education tool for people with visual impairments

Hungarian physician to receive the Körber Prize for European Science 2020

GlobalData: NGS technology most likely to provide relief for global backlog of COVID-19 testing

Nicoya receives NRC IRAP funding to develop saliva-based diagnostic test for COVID-19

Lehigh University receives funding to create functional material that kills coronavirus

Scientists create 'all-atom' model of SARS-CoV-2 spike protein

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News